New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Dastaar Movie Review: Tarsem Jassar’s Powerful Sikh Resilience Drama
- Diamond Made Man Part 2 Review: A Cosmic Sci-Fi Spectacle That Soars
- ‘Oka Court Case’ 2026 Movie Review: A Fresh Legal Love Drama That Wins Hearts
- Rahun Main Tere Rubaru Review: A Gripping Tale of Love, Danger & Deception
- ‘Vadala’ Movie Review: A Gripping Psychological Thriller With Powerhouse Performances
- Oh! Sukumari Movie Review: Thiruveer, Aishwarya Rajesh Spark Pure Magic in This Rural Entertainer
- MRP (Neekentha Naakentha) Movie Review: A Hilarious Corpse-Swap Comedy You Can’t Miss
- Arulvaan Movie Review: Arulnithi’s Powerful Drama Is a Heartfelt Ode to Education